Skip to main content
. 2022 Nov 19;14(11):2523. doi: 10.3390/pharmaceutics14112523

Figure 7.

Figure 7

Development strategy for peptide-based ER-PROTACs. (A) Generalized structures and possible cases of derivatization. (B) Yielded peptide-PROTACs.